RU51500U1 - GAS MIXTURE THERAPY SYSTEM IN THE COMPLEX TREATMENT OF ASTENO-DEPRESSIVE STATES IN THE CLINIC OF BOUNDARY NERVO-PSYCHIC DISORDERS - Google Patents

Abstract

The utility model relates to preventive medicine, in particular, to equipment for the treatment of gas mixtures in the complex treatment of asthenic-depressive conditions in the clinic of borderline neuropsychiatric disorders. The essence of the utility model is that the gas supply unit of the gas mixture therapy system in the complex treatment of astheno-depressive conditions in the clinic of borderline neuropsychiatric disorders is equipped with a device for generating the antidepressant effect performed and in the form of inert gas cylinders connected to an anesthesia apparatus, the dosimeters of which are calibrated with oxygen and inert gases and the inert gas collection unit, and the inert gas supply unit is made with a fixed gas flow output of 0.55-1.1-1.65-2.4 liters / min, When this system analyzer therapy has inspired and expired gases tonometer stethoscope set for intubation - laryngoscope, endotracheal tubes, elektrodefibllyator, heart monitor, aspirator medical, spatial placement elements ampules - 1000 ml. 5% glucose solution, 2 ml. 0.5% diazepam solution, 10 ml. 0.25% droperidol solution, 1 ml. 5% solution of vitamin B-1, 2 ml. 5% solution of ascorbic acid, 2 ml. 5% solution of vitamin B-6, 1 ml each. vitamin B-12, 1 ml each. 5% solution of vitamin E, 2.0 ml. 5% ascorbic acid solution, phenobarbital tablets in 0.1 g tablets and sterile lines for single-use intravenous infusions, and the patient's placement unit has movable stop elements.

Description

The utility model relates to preventive medicine, in particular, to equipment for the treatment of gas mixtures in the complex treatment of asthenic-depressive conditions in the clinic of borderline neuropsychiatric disorders. A well-known gas mixture therapy system in the complex treatment of asthenic-depressive conditions in the clinic of borderline neuropsychiatric disorders, including interconnected functional units - patient placement unit, anesthesia apparatus, gas supply unit, connection elements and face masks, / cm. Patent R.F. 2128534, class A 61 M 16/00, 1996 /.

A gas mixture therapy system is also known in the complex treatment of asthenic-depressive conditions in the clinic of borderline neuropsychiatric disorders, including interconnected functional units - a patient placement unit, anesthesia apparatus, gas supply unit, connection elements and face masks, / cm. Patent R.F. 2146536, cl. A 61 M 16/00, 1999 /.

The disadvantages of the known utility models are the significant periods of prophylaxis and treatment of this category of patients and the unstable antidepressant effect in the early stages of treatment and prophylaxis, which leads to increased drug loading and costs, high severity of symptoms of asthenia and somatic complications, which worsens the prognosis for recovery and social adaptation.

The purpose of the utility model is to reduce the terms of prevention and treatment of this category of patients and increase the antidepressant effect in the early stages of treatment and prevention, which leads to a decrease in the drug load and costs, a decrease in the severity of asthenia symptoms and somatic complications, which improves the prognosis for recovery and social adaptation.

This is achieved by the fact that the gas supply unit of the gas mixture therapy system for the complex treatment of astheno-depressive conditions in the clinic of borderline neuropsychiatric disorders is equipped with a device for generating an antidepressant effect made in the form of cylinders of inert gases connected to an anesthesia apparatus, the dosimeters of which are calibrated with oxygen and inert gases and an inert gas collection unit, wherein the inert gas supply unit is made with a fixed gas flow output of 0.55-1.1-1.65-2.2 liters / min, while the system rapii analyzer has inhaled and exhaled gases tonometer stethoscope set for intubation - laryngoscope, endotracheal tubes, elektrodefibllyator, heart monitor, aspirator medical, spatial placement elements ampules - 1000 ml. 5% glucose solution, 2 ml. 0.5% diazepam solution, 10 ml. 0.25% droperidol solution, 1 ml. 5% solution of vitamin B-1, 2 ml. 5% solution of ascorbic acid, 2 ml. 5% solution of vitamin B-6, 1 ml each. vitamin B-12, 1 ml each. 5% solution of vitamin E, 2.0 ml. 5% ascorbic acid solution, phenobarbital tablets in 0.1 g tablets and sterile lines for single-use intravenous infusions, and the patient's placement unit has movable stop elements.

It is advisable that the gas supply unit was installed with the release of oxygen and inert gas in the ratio 1: 1.

It is useful that the anesthesia machine be installed with a frequency of sessions, depending on the exacerbation of the neuro-vegetative symptom complex.

It is advisable that the anesthesia apparatus be installed with a frequency of sessions depending on the exacerbation of the pain symptom complex.

It is useful that the anesthesia apparatus be installed with a frequency of sessions depending on the exacerbation of the neurovegetative and painful symptom complex.

It is advisable that the anesthesia machine be installed with a frequency of sessions depending on the growth of autonomic disorders.

It is useful that the anesthesia machine be installed with a frequency of sessions depending on the growth of tachycardia.

It is advisable that the anesthesia machine be installed with a frequency of sessions depending on the growth of autonomic disorders.

It is useful that the anesthesia machine be installed with a frequency of sessions depending on the growth of weakness.

It is advisable that the anesthesia apparatus be installed with a frequency of sessions depending on the growth of yawning.

It is useful that the anesthesia apparatus be installed with a frequency of sessions depending on the increase in motor inhibition.

It is advisable that the anesthesia machine be installed with a frequency of sessions depending on the increase in lethargy.

It is useful that the anesthesia machine be installed with a frequency of sessions depending on the increase in anxiety.

It is advisable that the anesthesia apparatus be installed with a frequency of sessions depending on the increase in apathy.

It is useful that the gas supply assembly has phenobarbital ampoules.

The gas mixture therapy system in the complex treatment of astheno-depressive conditions in the clinic of borderline neuropsychiatric disorders corresponds to all the features of a useful model, namely -

- the presence of a structural element, since the gas supply unit of the gas mixture therapy system in the complex treatment of asteio-depressive conditions in the clinic of borderline neuropsychiatric disorders is equipped with a device for the formation of an antidepressant effect

- the presence of a connection between the elements, since the device for forming the antidepressant effect is made in the form of inert gas cylinders

- the presence of the location of the element, since the device for the formation of the antidepressant effect is connected to the anesthesia apparatus

- the form of the element, since the dosimeters of the device are calibrated with oxygen and inert gases

- a form of communication with honey elements, since the inert gas supply unit is made with a fixed gas flow - 0.55-1.1-1.65-2.2 liters / min,

- parameters and other characteristics of the element, since the therapy system has a gas analyzer of inhaled and exhaled gases, a tonometer, a phonendoscope, a set for tracheal intubation - a laryngoscope, endotracheal tubes, an electric defibulator, a cardiomonitor, a medical suction tube, and ampoules with spatial placement of 1000 ml 5% glucose solution, 2 ml. 0.5% diazepam solution, 10 ml. 0.25% droperidol solution, 1 ml. 5% solution of vitamin B-1, 2 ml. 5% solution of ascorbic acid, 2 ml. 5% solution of vitamin B-6, 1 ml each. vitamin B-12, 1 ml each. 5% solution of vitamin E, 2.0 ml. 5% ascorbic acid solution, phenobarbital tablets in 0.1 g tablets and sterile single-use intravenous infusion lines, the material of which is made of an element, since the patient's placement unit has movable stop elements.

Figure 1 shows a structural diagram of a therapy system.

Figure 2 is the same, the scheme of the gas mixture therapy system in the complex treatment of astheno-depressive conditions in the clinic of borderline neuropsychiatric disorders.

The gas mixture therapy system in the complex treatment of astheno-depressive conditions in the clinic of borderline neuropsychiatric

disorders including interconnected functional nodes - a host unit for 1 patient, an anesthesia machine 2, a gas supply unit 3, connection elements 4 and face masks 5, while a gas supply unit 3 of a gas mixture therapy system in the complex treatment of asthenic-depressive conditions in a border clinic of neuropsychiatric disorders is equipped with a device for the formation of an antidepressant effect 6 made in the form of cylinders 7 of inert gases connected to anesthesia apparatus 2, dosimeters of which 8 are calibrated with oxygen and inert gases and the inert gas collection unit 9, and the 3 gas supply unit is made with a fixed gas flow output of 0.55-1.1-1.65-2.2 liters / min, while the therapy system has a gas analyzer 10, inhaled and expired gas 11, tonometer 12, phonendoscope 13, set 14 for tracheal intubation - a laryngoscope, endotracheal tubes, electric defibrillator, cardiomonitor, medical aspirator, ampoules of spatial arrangement of 15 ampoules of 1000 ml each. 5% glucose solution 16, 2 ml. 0.5% solution of diazepam 17, 10 ml. 0.25% solution of droperidol 18, 1 ml. 5% solution of vitamin B-1 19, 2 ml. 5% solution of ascorbic acid 20, 2 ml. 5% solution of vitamin B-6 21, 1 ml each. Vitamin B-12 22, 1 ml each. A 5% solution of vitamin E 23, 24 - phenobarbital, in tablets of 0.1 g 25 and sterile lines 26 for single-use intravenous infusions, and the patient’s placement unit 1 has movable locking elements 27, the gas supply unit 3 is installed with the release of oxygen and inert gas in ratios of 1: 1, and anesthesia apparatus 2 is set with a frequency of sessions depending on the exacerbation of the neurovegetative symptom complex, or depending on the exacerbation of the pain symptom complex, or depending on the exacerbation of the neurovegetative and pain symptom complex Or, depending on the growth of vegetative disorders, or depending on the swells of tachycardia, or depending on the vegetative growth of the violation, or

depending on an increase in weakness, or depending on an increase in yawning, depending on an increase in motor lethargy, or depending on an increase in lethargy, or depending on an increase in anxiety, or on an increase in apathy, and the gas supply unit has phenobarbital ampoules.

The treatment system is as follows.

Initially, interconnected functional units are prepared for operation — a patient placement unit 1, an anesthesia machine 2, a gas supply unit 3, connection elements 4 and face masks 5, while a gas supply unit 3 of a gas mixture therapy system in the complex treatment of asthenic-depressive conditions the clinic of borderline neuropsychiatric disorders is equipped with a device for forming an antidepressant effect 6, which is performed in the form of cylinders 7 of inert gases connected to anesthesia apparatus 2, dosimeters of which 8 calibrate about oxygen and inert gases and the inert gas collection unit 9, and the gas supply unit 3 is carried out with a fixed gas flow output of 0.55-1.1-1.65-2.2 liters / min, while the therapy system is equipped with a gas analyzer 10 inhaled and exhaled gases, a tonometer 12, a phonendoscope 13, a set 14 for tracheal intubation - a laryngoscope, endotracheal tubes, electric defibrillator, cardiomonitor, medical aspirator, ampoules of 15 ampoules of 15 - 1000 ml. 5% glucose solution 16, 2 ml. 0.5% solution of diazepam 17, 10 ml, 0.25% solution of droperidol 18, 1 ml. 5% solution of vitamin B-1 19, 2 ml. 5% solution of ascorbic acid 20, 2 ml. 5% solution of vitamin B-6 21, 1 ml each. Vitamin B-12 22, 1 ml each. 5% solution of vitamin E 23, 2.0 ml. 5% solution of ascorbic acid 24, phenobarbital in tablets of 0.1 g 25 and sterile highways 26 for

single-use intravenous infusions, and the patient's accommodation unit 1 is provided with movable stop elements 27, the gas supply unit 3 is installed with the delivery of oxygen and inert gas in 1: 1 ratios, and the anesthesia device 2 is set with a frequency of sessions depending on the exacerbation of the neuro-vegetative symptom complex, or depending on the exacerbation of the pain symptom complex, or depending on the exacerbation of the neurovegetative and pain symptom complex, or depending on the growth of autonomic disorders, or depending on the race of tachycardia, or depending on the growth of vegetative disorders, or depending on the growth of weakness, or depending on the increase in yawning, depending on the increase in motor lethargy, or depending on the increase in lethargy, or depending on the increase in anxiety, or depending on an increase in apathy, and the gas supply unit is supplied with phenobarbital ampoules, then the patient is placed on the placement unit 1, fixed with movable locking elements and all the required procedures are carried out based on beforehand prepared solutions and tablets, after which the movable locking elements are unlocked, the patient is moved to a stationary place and the cycle is repeated.

XENON as a treatment for astheno-depressive conditions and other mental disorders in the treatment of acute encephalopathy in a narcological clinic.

The main advantage of the technique is the possibility, with the help of xenon therapy, to cause a clear reduction in the clinical manifestations of acute encephalopathy and polyneuropathy in patients with a narcological profile:

- stop hallucinatory-delusional disorders within the framework of the psycho-organic syndrome;

- improve cognitive function;

- stop acute cortical, mesencephalic, diencephalic and cerebellar neurological disorders;

- stabilize autonomic regulation.

Patient “C” 50 years old, (IB 18555) was admitted to the NKB No. 17 for the purpose of treatment for alcoholism, and in connection with auditory and visual hallucinations that appeared against the background of alcohol withdrawal. Previously treated three times in a hospital.

Hallucinations during the period of withdrawal symptoms persisted for a long time (up to three weeks), did not stop with the use of antipsychotics. Moreover, taking antipsychotic drugs worsened the patient's condition. Ataxia, dysarthria, disorientation in place and time appeared, and memory worsened.

The patient began to regularly take alcohol in the last five years, after retirement. She worked as a trolley bus driver.

History of repeated traumatic brain injury (concussion), dyscirculatory encephalopathy, otosclerosis.

Auditory and visual hallucinations appear on the background of alcohol withdrawal syndrome for the past 2 years. He sees relatives sitting on the ceiling or on the window and scolding her for drinking alcohol.

Orientation in place and time is saved. Answers to questions in terms of the given, verbose, not always in essence, "jumping" from one thought to another, speech is fast, loud, jerky. The mood is benign, elated. He reports anamnestic data completely, flaunts his drunkenness. He is critical of hallucinations, realizing that these are deceptions of perception, but believes that she was “spoiled”.

Given the history and Harocter of hallucinatory-delusional disorders, endogenous disease was included.

The patient willingly agreed to xenon therapy, immediately after the doctor’s approval, believing that the procedure would help her.

Xenon therapy sessions went smoothly. Hemodynamics and respiration were stable. Immediately after the first session, the hallucinations disappeared, the patient calmed down and fell asleep. In the following days, the mood background, night's sleep returned to normal. On the second and third day of treatment, hallucinatory symptoms appeared in the evening and only in the form of an unclear whisper or illegible words and immediately stopped with xenon inhalations for 3 to 4 minutes.

On the fifth day, the patient was in satisfactory condition transferred from the intensive care unit and intensive care unit to the narcological department, where vitamin therapy, vascular therapy, physiotherapy, and rational psychotherapy continued. Tranquilizers, sleeping pills, antipsychotics

the patient did not receive antidepressants and other psychocorrectors. After 30 days, the patient was discharged from the hospital in satisfactory condition.

Patient "I" 55 years old, (IB No. 12459) was transferred to the NKB No. 17 from the neurological department of the GKB No. 7, where he stayed for 20 days with a diagnosis of

Toxic encephalopathy with episindrome. Korsakovsky syndrome. Right upper lobar pneumonia. Retinal angiopathy.

The condition at admission is serious: it is sharply inhibited, disoriented in place and time, it answers monosyllables, dysortria, gross cerebellar and diencephalic disorders, fixative amnesia. Clinically and radiologically revealed right-sided upper lobar pneumonia, on the ECG - signs of decreased coronary blood flow in the anterior wall of the left ventricle.

When collecting an anamnesis (according to the son), it was found that the patient has been abusing alcohol for a long time, more than 20 years. Over the past 10 years, drinking has been practically permanent. Over the past 4 years, against the background of alcohol withdrawal, epipressures have appeared. A sick surgeon by profession, candidate of medical sciences, associate professor was engaged in medical and teaching activities. The last 5 years he has been working as a consultant in a children's clinic. For a long time the patient treated withdrawal symptoms on his own, hid his alcohol addiction from others, did not turn to a narcologist for help. Before entering the neurological department, City Clinical Hospital No. 7 was found by relatives of the house unconscious, which was the reason for hospitalization.

Given the signs of acute acute toxic toxic encephalopathy, it was decided to conduct a course of xenon therapy.

Xenon therapy sessions were carried out daily for 12 days. In parallel, general strengthening therapy, cerebrovascular therapy, and vitamin therapy were carried out.

During xenon therapy sessions, stabilization of hemodynamic and respiratory parameters, muscle relaxation, and deep sleep for 3 to 4 hours after the completion of the session were noted.

After the third session, the patient began to clearly improve neurological neuropsychiatric symptoms:

- the patient became more active in the daytime and night sleep normalized;

- the speech became clear and emotionally colored;

- memory for current and past events has clearly improved, while professional memory was the first to recover;

- There was a critical attitude to his condition and illness and a desire to recover.

On the seventh day of treatment, the patient began to get out of bed, from the beginning with the help of medical staff, and then, on his own.

On the 12th day of treatment, the patient was transferred to the narcological department where vasocerebral, metabolic and vitamin therapy was continued, as well as physiotherapy and psychotherapy.

2.5 months after admission, the patient was discharged from the hospital in a relatively satisfactory condition.

Claims (3)

1. The gas mixture therapy system in the complex treatment of asthenic-depressive conditions in the clinic of borderline neuropsychiatric disorders, which includes interconnected functional units: patient placement unit, anesthesia apparatus, gas supply unit, inhaled and exhaled gas analyzer, connection elements and face masks , characterized in that the gas supply unit of the gas mixture therapy system in the complex treatment of astheno-depressive conditions in the clinic of borderline neuropsychiatric disorders is provided with the benefit of the formation of the antidepressant effect, made in the form of inert gas cylinders connected to an anesthesia apparatus, the dosimeters of which are calibrated with oxygen and inert gas, and an inert gas collection unit, and the inert gas supply unit is made with a fixed gas flow output of 0.55-1, 1 ÷ 1.65-2.2 liters / min, while the therapy system has a tonometer, phonendoscope, a set for tracheal intubation - a laryngoscope, endotracheal tubes, electrodefibrillator, cardiomonitor, medical aspirator, elements of spatial p placements of vials of - 1000 ml of 5% glucose solution, 2 ml of 0.5% diazepam solution, 10 ml of 0.25% droperidol solution, 1 ml of 5% vitamin B-1 solution, 2 ml of 5% ascorbic acid solution, 2 ml 5 % solution of vitamin B-6, 1 ml of vitamin B-12, 1 ml of 5% solution of vitamin E, 2.0 ml of 5% solution of ascorbic acid, phenobarbital in tablets of 0.1 g and sterile lines for intravenous infusion of single use and the patient placement unit has movable locking elements. 2. The system according to claim 1, characterized in that the gas supply unit is installed with the delivery of oxygen and inert gas in ratios of 1: 1. 3. The system according to claim 1, characterized in that the gas supply unit has phenobarbital ampoules.